Showing 121-140 of 646 for: Cochrane Systematic Reviews > Psychiatric and substance abuse 
- Cholinesterase inhibitors for delirium
Cochrane Systematic Reviews, 22-Oct-2008
Delirium is now the preferred term to describe acute confusional states. It is experienced by 10 to 30% of all hospital inpatients. Delirium is potentially reversible and is related to several adverse outcomes, including increased hospital length of stay,
- Cholinesterase inhibitors for dementia with Lewy bodies
Cochrane Systematic Reviews, 27-Apr-2008
Dementia with Lewy bodies (DLB) was first described in 1983, and clinical diagnostic criteria were published in the early to mid 1990s. It has been suggested DLB may account for up to 15-25% of cases of dementia among people aged over 65, although autopsy
- Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease
Cochrane Systematic Reviews, 13-Feb-2012
Previous Cochrane reviews have considered the use of cholinesterase inhibitors in both Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB). The clinical features of DLB and PDD have much in common and are distinguished primarily on
- Cholinesterase inhibitors for Parkinson's disease dementia
Cochrane Systematic Reviews, 5-May-2008
The loss of cholinergic, dopaminergic and noradrenergic innervations seen in Parkinson's Disease Dementia (PDD) suggest a potential role for cholinesterase inhibitors. Concerns have been expressed about a theoretical worsening of Parkinson's disease relat
- Citalopram versus other anti-depressive agents for depression
Cochrane Systematic Reviews, 12-Jun-2012
Recent US and UK clinical practice guidelines recommend that second-generation antidepressants should be considered amongst the best first-line options when drug therapy is indicated for a depressive episode. Systematic reviews have already highlighted so
- Clonidine for smoking cessation
Cochrane Systematic Reviews, 31-Jul-2008
Clonidine was originally used to lower blood pressure. It acts on the central nervous system and may reduce withdrawal symptoms in various addictive behaviours, including tobacco use.
- Clotiapine for acute psychotic illnesses
Cochrane Systematic Reviews, 25-Jul-2012
Acute psychotic illnesses, especially when associated with agitated or violent behaviour, require urgent pharmacological tranquillisation or sedation. Clotiapine, a dibenzothiazepine neuroleptic, is being used for this purpose in several countries.
- Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia
Cochrane Systematic Reviews, 8-Feb-2010
Although clozapine has been shown to be the treatment of choice in people with schizophrenia that are resistant to treatment, one third to two thirds of people still have persistent positive symptoms despite clozapine monotherapy of adequate dosage and du
- Clozapine versus other atypical antipsychotics for schizophrenia
Cochrane Systematic Reviews, 9-Nov-2010
Clozapine is an atypical antipsychotic demonstrated to be superior in the treatment of refractory schizophrenia which causes fewer movement disorders. Clozapine, however, entails a significant risk of serious blood disorders such as agranulocytosis which
- Clozapine versus typical neuroleptic medication for schizophrenia
Cochrane Systematic Reviews, 10-Nov-2009
Long-term drug treatment of schizophrenia with typical antipsychotic drugs has limitations: 25 to 33% of sufferers have illnesses that are treatment resistant. Clozapine is an antipsychotic drug, which is claimed to have superior efficacy and to cause few
- Cognition-based interventions for healthy older people and people with mild cognitive impairment
Cochrane Systematic Reviews, 7-Dec-2010
Evidence from some, but not all non-randomised studies suggest the possibility that cognitive training may influence cognitive functioning in older people. Due to the differences among cognitive training interventions reported in the literature, giving a
- Cognitive behaviour therapy for chronic fatigue syndrome in adults
Cochrane Systematic Reviews, 12-Feb-2009
Chronic fatigue syndrome (CFS) is a common, debilitating and serious health problem. Cognitive behaviour therapy (CBT) may help to alleviate the symptoms of CFS.
- Cognitive behavioural interventions for sleep problems in adults aged 60+
Cochrane Systematic Reviews, 11-Nov-2008
The prevalence of sleep problems in adulthood increases with age. While not all sleep changes are pathological in later life, severe disturbances may lead to depression, cognitive impairments, deterioration of quality of life, significant stresses for car
- Cognitive behavioural therapy for anxiety disorders in children and adolescents
Cochrane Systematic Reviews, 16-Dec-2014
A previous Cochrane review (James 2005) showed that cognitive behavioural therapy (CBT) was effective in treating childhood anxiety disorders; however, questions remain regarding (1) the relative efficacy of CBT versus non-CBT active treatments; (2) the r
- Cognitive behavioural therapy for men who physically abuse their female partner
Cochrane Systematic Reviews, 10-Jul-2012
In national surveys, between 10% and 34% of women have reported being physically assaulted by an intimate male partner. Cognitive behavioural therapy (CBT) or programmes including elements of CBT are frequently used treatments for physically abusive men.
- Cognitive behavioural therapy for tinnitus
Cochrane Systematic Reviews, 1-Aug-2010
This is an update of a Cochrane Review originally published in Issue 1, 2007 of The Cochrane Library.
- Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia
Cochrane Systematic Reviews, 25-Sep-2015
Cognitive behavioural therapy (CBT) is now a recommended treatment for people with schizophrenia. This approach helps to link the person's distress and problem behaviours to underlying patterns of thinking.
- Cognitive reframing for carers of people with dementia
Cochrane Systematic Reviews, 13-Sep-2011
The balance of evidence about whether psychosocial interventions for caregivers of people with dementia could reduce carers' psychological morbidity and delay their relatives' institutionalisation is now widely regarded as moderately positive (Brodaty 200
- Cognitive rehabilitation for people with schizophrenia and related conditions
Cochrane Systematic Reviews, 28-Oct-2008
Researchers have consistently found that people with schizophrenia score more poorly than others on a wide array of cognitive tasks and that these deficits persist even when the illness is in remission. The perceived impact of cognitive impairment on day-
- Cognitive stimulation to improve cognitive functioning in people with dementia
Cochrane Systematic Reviews, 17-Jan-2012
Cognitive stimulation is an intervention for people with dementia which offers a range of enjoyable activities providing general stimulation for thinking, concentration and memory usually in a social setting, such as a small group. Its roots can be traced
